🌟 Welcome Susan Wierzbicki to our #QualityAssurance team as a Senior Auditor! 👏
With 20+ years in GCP audit management, compliance & vendor qualification, most recently at TKL Research, she brings deep expertise to #NSPharma. We’re thrilled to have you, Susan! 💙 https://x.com/NSPharmaInc/status/1987898435870032358/photo/1
Please join us in welcoming Marcel Bourgeois to #NSPharma as National Director!
With 15+ years in #PatientAccess, including leadership at Takeda, he’s launched programs & teams improving access for rare disease patients. Excited to have you aboard!
We are conducting a Phase 2 #ClinicalTrial evaluating NS-229, an investigational JAK1 inhibitor, to learn more about potential new treatment options for adults with #EGPA.
See if you are eligible to join:
https://clinicaltrials.gov/study/NCT06046222#participation-criteria